Expert Opinion on Drug Safety

Antithrombotic treatment in atrial fibrillation
pp. 485-486(2)
Authors: Borja, Javier; García, Olga; Izquierdo, Iñaki

Ezetimibe: effective and safe treatment for dyslipidaemia associated with nonalcoholic fatty liver disease
pp. 487-488(2)
Authors: Ahmed, Mohamed H; Saad, Rasheed A; Osman, Meissa M

Prescribing errors resulting in adverse drug events: how can they be prevented?
pp. 489-493(5)
Authors: Thürmann, Petra A

The challenge of effectively communicating pateint safety information
pp. 495-499(5)
Authors: Hugman, Bruce; Edwards, I Ralph

Practical considerations for carbamazepine use in bipolar disorder
pp. 501-509(9)
Authors: Fuller, Matthew A; Dostrow, Victor; Gupta, Sanjay; Gazda, Thomas D

Folic acid and cognition in older persons
pp. 511-522(12)
Authors: Schneider, Julie A; Tangney, Christy C; Morris, Martha Clare

The effect of antidepressants on lipid homeostasis: a cardiac safety concern?
pp. 523-537(15)
Authors: McIntyre, Roger S; Soczynska, Joanna K; Konarski, Jakub Z; Kennedy, Sidney H

Safety aspects of aprotinin therapy in cardiac surgery patients
pp. 539-552(14)
Authors: Royston, David; Chhatwani, Asha

Incidence and management of bevacizumab-related toxicities in colorectal cancer
pp. 553-566(14)
Authors: Saif, M Wasif; Mehra, Ranee

Drug-induced phospholipidosis: issues and future directions
pp. 567-583(17)
Authors: Reasor, Mark J; Hastings, Kenneth L; Ulrich, Roger G

Drug-induced side effects affecting the gastrointestinal tract
pp. 585-592(8)
Authors: Leong, Rupert WL; Chan, Francis KL